Salud financiera de hoja de balance de Replimune Group
Salud financiera controles de criterios 5/6
Replimune Group tiene un patrimonio de los accionistas total de $381.5M y una deuda total de $45.6M, lo que sitúa su ratio deuda-patrimonio en 11.9%. Sus activos y pasivos totales son $498.2M y $116.7M respectivamente.
Información clave
11.9%
Ratio deuda-patrimonio
US$45.57m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$432.06m |
| Patrimonio | US$381.46m |
| Total pasivo | US$116.74m |
| Activos totales | US$498.20m |
Actualizaciones recientes sobre salud financiera
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Recent updates
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($442.6M) de REPL superan a sus pasivos a corto plazo ($43.8M).
Pasivo a largo plazo: Los activos a corto plazo de REPL ($442.6M) superan a sus pasivos a largo plazo ($73.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: REPL tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de REPL ha crecido de 8% a 11.9% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: REPL tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.
Pronóstico de cash runway: REPL dispone de suficiente cash runway para 2.1 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 30% cada año.